Space company Astra lays off 16% of workforce as it faces rocket development delay, quarterly losses

Space company Astra lays off 16% of workforce as it faces rocket development delay, quarterly losses


Astra CEO Chris Kemp speaks inside the company’s headquarters during the company’s “Spacetech Day” on May 12, 2022.

Brady Kenniston / Astra

Astra announced Tuesday it would lay off about 16% of its employees as the space company faces a pivot in its rocket development program.

“Given the challenging macroeconomic environment, we made the difficult but prudent decision to reduce our operating expenses to support our primary near-term objectives,” Astra CEO Chris Kemp said in a press release alongside the company’s third-quarter results.

Astra, which currently has over 400 employees, said it expects to see savings from the headcount reduction in the first quarter of 2023.

The company pivoted on its rocket system over the summer, ending development and flights of its Rocket 3.3 vehicle, in favor of a larger, upgraded Rocket 4.0 vehicle that Astra hopes to debut in late 2023. Astra is now building out its production facility and conducting testing an development of Rocket 4.0.

Sign up here to receive weekly editions of CNBC’s Investing in Space newsletter.

The company reported a third-quarter adjusted EBITDA loss of $41.4 million, a 26% larger loss than the same period a year prior. Astra brought in $2.8 million in revenue for the quarter from sales of its spacecraft engines. It had $150.5 million in cash on hand at the quarter’s end.

Astra stock is down 94% this year as of Tuesday’s close of $0.58 a share. The company received a de-listing warning from the Nasdaq in October after its stock fell below $1 a share. The company has until April to lift the stock price back above the level.



Source

FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share
Business

FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4, 2026. Tom Little | Reuters The Food and Drug Administration on Thursday approved a higher dose version of Novo Nordisk‘s blockbuster weight loss injection Wegovy, as the company pushes to win back market share from […]

Read More
Major League Baseball names Polymarket exclusive prediction market partner
Business

Major League Baseball names Polymarket exclusive prediction market partner

Shayne Coplan, chief executive officer of Polymarket, on the floor of the New York Stock Exchange (NYSE) in New York, US, on Thursday, Nov. 13, 2025. Michael Nagle | Bloomberg | Getty Images Major League Baseball on Thursday announced it was naming Polymarket its official prediction market partner. The association also signed a memorandum of […]

Read More
Real estate could be the big winner in the private credit exodus
Business

Real estate could be the big winner in the private credit exodus

A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight to your inbox. Barely […]

Read More